Provided by Tiger Trade Technology Pte. Ltd.

BOTANIX PHARMACEUTICALS LTD

0.020
0.000
Volume:1.82M
Turnover:36.83K
Market Cap:54.69M
PE:-0.43
High:0.021
Open:0.021
Low:0.020
Close:0.020
52wk High:0.170
52wk Low:0.018
Shares:2.73B
Float Shares:1.72B
Volume Ratio:0.47
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.046
EPS(LYR):-0.047
ROE:-121.11%
ROA:-53.38%
PB:1.01
PE(LYR):-0.43

Loading ...

Company Profile

Company Name:
BOTANIX PHARMACEUTICALS LTD
Exchange:
ASX
Establishment Date:
1984
Employees:
11
Office Location:
Tower 5, Collins Square,Level 23,727 Collins Street,Melbourne,Western Australia,Australia
Zip Code:
3008
Fax:
61 8 6210 1153
Introduction:
Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia. It offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX 1204, a transdermal gel formation for the treatment of atopic dermatitis; BTX 1701, a novel product for mild acne; and BTX 1801, a novel antimicrobial. The company is based in North Perth, Australia.